{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:37:06Z","timestamp":1788053826214,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T00:00:00Z","timestamp":1276041600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00432-010-0894-8","type":"journal-article","created":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T10:46:52Z","timestamp":1275994012000},"page":"615-620","source":"Crossref","is-referenced-by-count":8,"title":["Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer"],"prefix":"10.1007","volume":"137","author":[{"given":"Kenichi","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadao","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"894_CR1","unstructured":"Beatson GW (1895) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii:104\u2013107, 162\u2013165"},{"key":"894_CR2","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske DM, Cobeleigh MA (1996) Ovarian function in premenopausal woman treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718\u20131729","journal-title":"J Clin Oncol"},{"key":"894_CR3","first-page":"84","volume":"9","author":"RM Chapman","year":"1982","unstructured":"Chapman RM (1982) Effect of cytotoxic therapy on sexuality and gonadal function. Semin Oncol 9:84\u201394","journal-title":"Semin Oncol"},{"key":"894_CR4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood.V58.4.849.849","volume":"58","author":"RM Chapman","year":"1981","unstructured":"Chapman RM, Sutcliffe SB (1981) Protection of ovarian function by oral contraceptives in woman receiving chemotherapy for Hodgkin\u2019s Disease. Blood 58:849\u2013851","journal-title":"Blood"},{"key":"894_CR5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1200\/JCO.2005.03.0783","volume":"24","author":"M Colleoni","year":"2006","unstructured":"Colleoni M, Gelber S, Goldhirsch A et al (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: international breast cancer study group trial 13\u201393. J Clin Oncol 24:1332\u20131341","journal-title":"J Clin Oncol"},{"key":"894_CR6","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1200\/JCO.2005.05.551","volume":"23","author":"NE Davidson","year":"1999","unstructured":"Davidson NE, O\u2019Neill AM, Vukov AM, Osborne CK, Martino S, White DR, Abeloff MD (1999) Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101(E5188). J Clin Oncol 23:5973\u20135982","journal-title":"J Clin Oncol"},{"key":"894_CR7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (2005) Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687\u20131717","journal-title":"Lancet"},{"key":"894_CR8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/cncr.21385","volume":"104","author":"MN Fornier","year":"2005","unstructured":"Fornier MN, Modi S, Panageas KS, Norton L, Hudis C (2005) Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40\u00a0years and younger after adjuvant anthracycline and taxane. Cancer 104:1575\u20131579","journal-title":"Cancer"},{"key":"894_CR9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.2003.02.063","volume":"21","author":"IC Henderson","year":"2003","unstructured":"Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E III, Schilsky RL, Wood WC, Muss HB, Norton L (2003) Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21:976\u2013983","journal-title":"J Clin Oncol"},{"key":"894_CR10","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/jnci\/djg119","volume":"95","author":"International Breast Cancer Study Group (IBCSG)","year":"2003","unstructured":"International Breast Cancer Study Group (IBCSG) (2003) Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 95:1833\u20131846","journal-title":"J Natl Cancer Inst"},{"key":"894_CR11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8","volume":"39","author":"H Koyama","year":"1977","unstructured":"Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y, Terasawa T, Kosaki G, Yamamoto T, Wada A (1977) Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 39:1403\u20131409","journal-title":"Cancer"},{"key":"894_CR12","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa043681","volume":"352","author":"M Martin","year":"2005","unstructured":"Martin M, Pienkowski T, Mackey J et al (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352:2302\u20132313","journal-title":"N Engl J Med"},{"key":"894_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02967466","volume":"7","author":"M Matsumoto","year":"2000","unstructured":"Matsumoto M, Miyauchi M, Yamamoto N, Shishikura T, Imanaka N (2000) Investigation of menstruation recovery after LH-RH agonist therapy for premenopausal patients with breast cancer. Breast Cancer 7:237\u2013240","journal-title":"Breast Cancer"},{"key":"894_CR14","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djg133","volume":"95","author":"JL Pater","year":"2003","unstructured":"Pater JL, Parulekar WR (2003) Ovarian ablation as adjuvant therapy for premenopausal women with breast cancer\u2014another step forward. J Natl Cancer Inst 95:1811\u20131812","journal-title":"J Natl Cancer Inst"},{"key":"894_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/gyno.2001.6181","volume":"81","author":"B Pereyra Pacheco","year":"2001","unstructured":"Pereyra Pacheco B, M\u00e9ndez Ribas JM, Milone G, Fern\u00e1ndez I, Kvicala R, Mila T, Di Noto A, Contreras Ortiz O, Pavlovsky S et al (2001) Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 81:391\u2013397","journal-title":"Gynecol Oncol"},{"key":"894_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0959-8049(93)90569-2","volume":"29","author":"LM Reyno","year":"1992","unstructured":"Reyno LM, Levine MN, Skingley P, Arnold A, Abu Zahra H (1992) Chemotherapy induced amenorrhea in a randomized trial of adjuvant chemotherapy duration in breast cancer. Eur J Cancer 29:21\u201323","journal-title":"Eur J Cancer"},{"key":"894_CR17","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1210\/jc.81.12.4453","volume":"81","author":"T Saarto","year":"1996","unstructured":"Saarto T, Blomqvist C, Ehnholm C, Taskinen MR, Elomaa I (1996) Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer. J Clin Endocrinol Metab 81:4453\u20134457","journal-title":"J Clin Endocrinol Metab"},{"key":"894_CR18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A","volume":"65","author":"R Sutton","year":"1990","unstructured":"Sutton R, Buzdar AU, Hortobagyi GN (1990) Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 65:847\u2013850","journal-title":"Cancer"},{"key":"894_CR19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.coc.0000251398.57630.4f","volume":"30","author":"YL Tham","year":"2007","unstructured":"Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R (2007) The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 30:126\u2013132","journal-title":"Am J Clin Oncol"},{"key":"894_CR20","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/S0959-8049(01)00317-3","volume":"37","author":"L Vehmanen","year":"2001","unstructured":"Vehmanen L, Saarto T, Elomaa I, M\u00e4kel\u00e4 P, V\u00e4lim\u00e4ki M, Blomqvist C (2001) Long term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment. Eur J Cancer 37:2373\u20132378","journal-title":"Eur J Cancer"},{"key":"894_CR21","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1200\/JCO.2006.07.2793","volume":"24","author":"JM Walshe","year":"2006","unstructured":"Walshe JM, Denduluri N, Swain SM (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24:5769\u20135779","journal-title":"J Clin Oncol"},{"key":"894_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0885-3924(02)00379-2","volume":"23","author":"MA Weitzer","year":"2002","unstructured":"Weitzer MA, Moncello J, Jacobsen PB, Minton S (2002) A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 23:337\u2013345","journal-title":"J Pain Symptom Manage"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0894-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-010-0894-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0894-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T13:46:36Z","timestamp":1591364796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-010-0894-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,9]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1007\/s00432-010-0894-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,9]]}}}